Munafa Stock Market Course + Intraday & FNO calls 
Rigel Pharmaceuticals (RIGL) Technical (Analysis) Reports Rigel Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Rigel Pharmaceuticals (RIGL)
Technical Analysis Report for NASDAQ stock RIGL Rigel Pharmaceuticals. Dated: 02 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock RIGL Rigel Pharmaceuticals then click here. or read Experts views on Rigel Pharmaceuticals or Forecast & share price targets of Rigel Pharmaceuticals
Rigel Pharmaceuticals Opened at 33.99 and Closed at: 34.62, which is -0.35% of previous session's close. It moved within a range of 33.77 and 35.00
The session was a Bullish session with an average volume of 331100, which is 21.11% of previous session's volumes.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Golden cross was found 5 days back on short term averages
Support for tomorrow is 34.2 and resistance for tomorrow is 35.43
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 33.93, 33.23 resistance for tomorrow's hourly charts is 35.16, 35.69
10 Day SMA for Rigel Pharmaceuticals (RIGL) is 35.18 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Rigel Pharmaceuticals (RIGL) is 34.86 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Rigel Pharmaceuticals (RIGL) is 38.03 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 37.83 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Rigel Pharmaceuticals is 32.36 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Rigel Pharmaceuticals is at 34.86 and 200 DMA is at 32.36, while 50 DMA and 100 DMA are at 38.03 and 37.83 respectively
Rigel Pharmaceuticals (RIGL) moving average of 20 SMA is at 34.86 and 20 EMA is at 35.33
| Date | Closing Price | 20 SMA | 20 EMA |
| 02 Mon Mar | 34.62 | 34.86 | 35.33 |
| 27 Fri Feb | 34.74 | 34.93 | 35.41 |
| 26 Thu Feb | 35.71 | 34.93 | 35.48 |
| 25 Wed Feb | 34.62 | 34.91 | 35.46 |
| 24 Tue Feb | 34.51 | 34.94 | 35.55 |
| 23 Mon Feb | 34.26 | 35.08 | 35.66 |
Rigel Pharmaceuticals (RIGL) moving average of 50 SMA is at 38.03 and 50 EMA is at 36.88
| Date | Closing Price | 50 SMA | 50 EMA |
| 02 Mon Mar | 34.62 | 38.03 | 36.88 |
| 27 Fri Feb | 34.74 | 38.18 | 36.97 |
| 26 Thu Feb | 35.71 | 38.32 | 37.06 |
| 25 Wed Feb | 34.62 | 38.46 | 37.11 |
| 24 Tue Feb | 34.51 | 38.58 | 37.21 |
| 23 Mon Feb | 34.26 | 38.73 | 37.32 |
Rigel Pharmaceuticals (RIGL) moving average of 100 SMA is at 37.83 and 100 EMA is at 36.52
| Date | Closing Price | 100 SMA | 100 EMA |
| 02 Mon Mar | 34.62 | 37.83 | 36.52 |
| 27 Fri Feb | 34.74 | 37.78 | 36.56 |
| 26 Thu Feb | 35.71 | 37.72 | 36.6 |
| 25 Wed Feb | 34.62 | 37.65 | 36.62 |
| 24 Tue Feb | 34.51 | 37.59 | 36.66 |
| 23 Mon Feb | 34.26 | 37.52 | 36.7 |
Rigel Pharmaceuticals (RIGL) moving average of 200 SMA is at 32.36 and 200 EMA is at 33.1
| Date | Closing Price | 200 SMA | 200 EMA |
| 02 Mon Mar | 34.62 | 32.36 | 33.1 |
| 27 Fri Feb | 34.74 | 32.28 | 33.08 |
| 26 Thu Feb | 35.71 | 32.2 | 33.06 |
| 25 Wed Feb | 34.62 | 32.12 | 33.03 |
| 24 Tue Feb | 34.51 | 32.04 | 33.01 |
| 23 Mon Feb | 34.26 | 31.96 | 32.99 |
Rigel Pharmaceuticals has performed better than Trupanion Inc in short term. Holding Rigel Pharmaceuticals could be a better choice for now!
Tandem Diabetes has performed better than Rigel Pharmaceuticals in short term. You could have earned much better returns by investing in Tandem Diabetes, about 34.14% more returns!
Tg Therapeutics has performed better than Rigel Pharmaceuticals in short term. You could have earned much better returns by investing in Tg Therapeutics, about 3.25% more returns!
Summit Therapeutics has performed better than Rigel Pharmaceuticals in short term. You could have earned much better returns by investing in Summit Therapeutics, about 15.48% more returns!
Rigel Pharmaceuticals has performed better than Soleno Therapeutics in short term. Holding Rigel Pharmaceuticals could be a better choice for now!
Si Bone has performed better than Rigel Pharmaceuticals in short term. You could have earned much better returns by investing in Si Bone, about 0.92% more returns!
Rigel Pharmaceuticals has performed better than Ultragenyx Pharmaceutical in short term. Holding Rigel Pharmaceuticals could be a better choice for now!
Pacira Pharmaceuticals has performed better than Rigel Pharmaceuticals in short term. You could have earned much better returns by investing in Pacira Pharmaceuticals, about 5.6% more returns!
Rigel Pharmaceuticals has performed better than Mesoblast in short term. Holding Rigel Pharmaceuticals could be a better choice for now!
Agios Pharmaceuticals has performed better than Rigel Pharmaceuticals in short term. You could have earned much better returns by investing in Agios Pharmaceuticals, about 8.91% more returns!
Rigel Pharmaceuticals has performed better than Apellis Pharmaceuticals in short term. Holding Rigel Pharmaceuticals could be a better choice for now!
Rigel Pharmaceuticals has performed better than Aurinia Pharmaceuticals in short term. Holding Rigel Pharmaceuticals could be a better choice for now!
Biolife Solutions has performed better than Rigel Pharmaceuticals in short term. You could have earned much better returns by investing in Biolife Solutions, about 2.96% more returns!
Rigel Pharmaceuticals has performed better than Collegium Pharmaceutical in short term. Holding Rigel Pharmaceuticals could be a better choice for now!
Rigel Pharmaceuticals has performed better than Catalyst Pharmaceuticals in short term. Holding Rigel Pharmaceuticals could be a better choice for now!
Denali Therapeutics has performed better than Rigel Pharmaceuticals in short term. You could have earned much better returns by investing in Denali Therapeutics, about 0.78% more returns!
Enanta Pharmaceuticals has performed better than Rigel Pharmaceuticals in short term. You could have earned much better returns by investing in Enanta Pharmaceuticals, about 11.29% more returns!
Galapagos Nv has performed better than Rigel Pharmaceuticals in short term. You could have earned much better returns by investing in Galapagos Nv, about 2.89% more returns!
Rigel Pharmaceuticals has performed better than Icon Plc in short term. Holding Rigel Pharmaceuticals could be a better choice for now!
Rigel Pharmaceuticals Technical analysis of indicators
Price action analysis of Rigel Pharmaceuticals (RIGL) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Rigel Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Rigel Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Rigel Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Rigel Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Rigel Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 35.13 and Rigel Pharmaceuticals RIGL stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Rigel Pharmaceuticals RIGL stock. Volume based technical analysis of Rigel Pharmaceuticals RIGL stock is negative.
Rigel Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock RIGL Rigel Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And RIGL Experts View which covers a lot of information including buying and selling signals
RIGL future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Rigel Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Rigel Pharmaceuticals (RIGL) Technical (Analysis) Reports Rigel Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
